News from Arteriocyte

May 02, 2014, 09:30 ET

Arteriocyte awarded FDA IDE approval to initiate clinical evaluation of MAGELLAN® Bio-Bandage™ in Acute Deep Partial Thickness Thermal Injuries.

 Arteriocyte, Inc., a leading biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts, announced approval from the...

Dec 06, 2013, 17:39 ET

Arteriocyte Medical Systems, Inc. applauds CMS for adding Magellan® Bio-Bandage™ as an option for Medicare and Medicaid Patients with chronic wounds

 Arteriocyte Medical Systems, Inc., a leading biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts, announced...

Sep 26, 2013, 09:30 ET

Arteriocyte Awarded BARDA Contract Valued up to $101.1 Million for Advanced Development of Arteriocyte's Magellan® BioBandageTM for Thermal Radiation Injury

 Arteriocyte, Inc., a leading biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts, announced today that it...

Jun 03, 2013, 11:51 ET

Arteriocyte announces Launch of Compass Biomedical

 Arteriocyte, Inc., a leading biotechnology company that is focused on developing and enabling commercial stem cell based therapies announced...

Jan 31, 2013, 10:37 ET

Arteriocyte Receives FDA Approval to Initiate Cellular Therapy Trial for Treatment of Thermal Burn Wounds in Wounded Warriors

Arteriocyte, a leading biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts announced today approval from the Food...

Aug 21, 2012, 09:45 ET

NIH awards grant to Arteriocyte and its collaboration with The University of Utah and Dana Farber to develop its NANEX™ technology for use in Bone Marrow Transplant

Arteriocyte, a leading clinical stage biotechnology company developing cellular based therapies to treat human diseases, announced today the...

Jun 04, 2012, 09:30 ET

Arteriocyte Medical Systems announces another FDA approval for its Magellan® Technology

 Arteriocyte Medical Systems, Inc. announced today approval by the U.S. Food and Drug Administration (FDA) to manufacture and distribute the...

Apr 06, 2012, 11:07 ET

Arteriocyte Receives FDA Approval to Initiate Compartment Syndrome Trial for Amputation Prevention Focused on Wounded Warriors

Arteriocyte, a leading biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts announced today approval from the Food...

Dec 13, 2011, 18:43 ET

Arteriocyte Takes the Lead in Promoting Building Future Pipeline of Women in STEM Career Fields

 Don Brown, CEO of Arteriocyte Cellular Therapies Medical Systems (Arteriocyte) and Terri Sandu, Executive Director of Hard Hatted Women (HHW),...

Jul 20, 2011, 11:22 ET
Arteriocyte logo. (PRNewsFoto/Arteriocyte)

Arteriocyte Receives $1 Million Award From Ohio Third Frontier Program to Advance Its NANEX™ Technology Toward Clinical Use

Arteriocyte®, a leading clinical stage biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts that develops...

Jun 07, 2011, 09:30 ET
Arteriocyte logo. (PRNewsFoto/Arteriocyte)

Arteriocyte and the U.S. Army Institute of Surgical Research (USAISR) Sign a CRADA to Speed Development of Cellular Therapies for Orthopaedic Trauma

Arteriocyte™, a leading clinical stage biotechnology company with offices in Cleveland, Ohio, and Hopkinton, Massachusetts, that develops...

Jan 28, 2011, 09:30 ET
Arteriocyte logo. (PRNewsFoto/Arteriocyte)

Arteriocyte Receives FDA Approval to Move Forward with Critical Limb Ischemia Trial

Arteriocyte®, a leading clinical stage biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts that develops...

Dec 02, 2010, 07:30 ET
Arteriocyte logo. (PRNewsFoto/Arteriocyte)

Arteriocyte Announces the Launch of NANEX™ Stem Cell Expansion System at the Upcoming American Society of Cell Biology Meeting

Arteriocyte, Inc., a leading clinical stage biotechnology company with offices in Cleveland, Ohio, and Hopkinton, Massachusetts, that develops...

Jun 28, 2010, 10:00 ET
Arteriocyte logo. (PRNewsFoto/Arteriocyte)

Arteriocyte Named Top Biotech Start Up Venture by the Ohio Venture Association for 2010

Arteriocyte, Inc., was honored Friday by the Ohio Venture Association as a Venture of Year Award Finalist. Founded in 2004 to develop proprietary...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer